These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 18497964

  • 1. A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study.
    Yokoyama Y, Takano T, Nakahara K, Shoji T, Sato H, Yamada H, Yaegashi N, Okamura K, Kurachi H, Sugiyama T, Tanaka T, Sato A, Tase T, Mizunuma H.
    Oncol Rep; 2008 Jun; 19(6):1551-6. PubMed ID: 18497964
    [Abstract] [Full Text] [Related]

  • 2. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ, Liu SP, Wang XE.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):821-7. PubMed ID: 20207507
    [Abstract] [Full Text] [Related]

  • 3. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan 01; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 4. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
    Yoshinaga K, Niikura H, Ogawa Y, Nemoto K, Nagase S, Takano T, Ito K, Yaegashi N.
    Gynecol Oncol; 2007 Jan 01; 104(1):36-40. PubMed ID: 16889822
    [Abstract] [Full Text] [Related]

  • 5. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
    Kato S, Ohno T, Thephamongkhol K, Chansilpa Y, Yuxing Y, Devi CR, Bustam AZ, Calaguas MJ, de los Reyes RH, Cho CK, Dung TA, Supriana N, Mizuno H, Nakano T, Tsujii H.
    Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):751-7. PubMed ID: 19836154
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501).
    Niibe Y, Hayakawa K, Tsunoda S, Kanai T, Imai M, Arai M, Arai T, Kawaguchi M, Jobo T, Hamada Y, Yago K, Unno N, Kitasato Gynecologic Radiation Oncology Group.
    Jpn J Clin Oncol; 2007 Jan 01; 37(1):70-2. PubMed ID: 17204507
    [Abstract] [Full Text] [Related]

  • 7. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.
    Gynecol Oncol; 2009 Jan 01; 112(1):85-9. PubMed ID: 18977518
    [Abstract] [Full Text] [Related]

  • 8. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
    Kobayashi Y, Ohara T, Wada Y, Okuda Y, Kondo H, Okuma Y, Suzuki N, Gomi H, Kiguchi K, Ishizuka B.
    J Obstet Gynaecol Res; 2009 Jun 01; 35(3):490-4. PubMed ID: 19527388
    [Abstract] [Full Text] [Related]

  • 9. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
    Lee MY, Wu HG, Kim K, Ha SW, Kim JS, Kim IA, Lee HP.
    Gynecol Oncol; 2007 Jan 01; 104(1):95-9. PubMed ID: 16996117
    [Abstract] [Full Text] [Related]

  • 10. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T, Moromizato H, Ogawa K, Kakinohana Y, Maehama T, Kanazawa K, Murayama S.
    Gynecol Oncol; 2005 Mar 01; 96(3):665-70. PubMed ID: 15721409
    [Abstract] [Full Text] [Related]

  • 11. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E, Omrcen T, Novaković ZS, Jelavić TB, Prskalo T, Hrepić D, Hamm W.
    Gynecol Oncol; 2006 Nov 01; 103(2):494-9. PubMed ID: 16814371
    [Abstract] [Full Text] [Related]

  • 12. [Concurrent weekly nedaplatin-based radiotherapy for high risk, recurrent and advanced cervical cancer].
    Idei T, Sakamoto H, Nakajima Y, Hiraiwa Y, Takami N, Chishima F, Ohtani K, Nagaishi M, Yamamoto T, Kawamori J, Himi K, Tanaka Y.
    Gan To Kagaku Ryoho; 2003 Apr 01; 30(4):505-9. PubMed ID: 12722682
    [Abstract] [Full Text] [Related]

  • 13. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Gynecol Oncol; 2008 Jan 01; 108(1):195-200. PubMed ID: 17963825
    [Abstract] [Full Text] [Related]

  • 14. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).
    Classe JM, Rauch P, Rodier JF, Morice P, Stoeckle E, Lasry S, Houvenaeghel G, Groupe des Chirurgiens de Centre de Lutte Contre le Cancer.
    Gynecol Oncol; 2006 Sep 01; 102(3):523-9. PubMed ID: 16504274
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer.
    Kim K, Chie EK, Wu HG, Ha SW, Kim JS, Kim IA, Lee HP.
    Gynecol Oncol; 2006 Jun 01; 101(3):398-402. PubMed ID: 16330087
    [Abstract] [Full Text] [Related]

  • 16. A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix.
    Yuan G, Wu L, Huang M, Li N, An J.
    Radiat Oncol; 2014 Feb 18; 9():55. PubMed ID: 24533532
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
    Novetsky AP, Einstein MH, Goldberg GL, Hailpern SM, Landau E, Fields AL, Mutyala S, Kalnicki S, Garg M.
    Gynecol Oncol; 2007 Jun 18; 105(3):635-40. PubMed ID: 17331568
    [Abstract] [Full Text] [Related]

  • 18. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
    Adachi S, Ogasawara T, Tsubamoto H, Oku H, Hori Y, Tsuji Y, Takemura T, Koyama K.
    Int J Clin Pharmacol Res; 2001 Jun 18; 21(3-4):105-10. PubMed ID: 12067139
    [Abstract] [Full Text] [Related]

  • 19. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
    Tacev T, Vacek A, Ptácková B, Strnad V.
    Strahlenther Onkol; 2005 May 18; 181(5):273-84. PubMed ID: 15900423
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
    Li XF, Li YH, Gao YN, Li CL, Yue HZ, Xu G, Li DM, Su X.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct 18; 48(10):763-7. PubMed ID: 24406134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.